Anterix Inc.
ATEX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | 0.84 | -0.12 | 0.77 |
| FCF Yield | -0.66% | -3.25% | -0.40% | -0.38% |
| EV / EBITDA | 19.15 | -60.68 | -54.37 | -51.04 |
| Quality | ||||
| ROIC | 7.59% | 2.85% | 2.39% | -4.41% |
| Gross Margin | 91.26% | 100.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | 0.03 | -0.12 | -1.80 | -1.00 |
| Growth | ||||
| Revenue 3-Year CAGR | 27.69% | 39.29% | 46.48% | 53.06% |
| Free Cash Flow Growth | 85.78% | -877.64% | 16.03% | 65.35% |
| Safety | ||||
| Net Debt / EBITDA | -1.57 | 3.99 | 2.33 | 2.89 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -4,462.84 | 650.09 | 468.22 | -3,523.46 |